Market revenue in 2023 | USD 69.7 million |
Market revenue in 2030 | USD 103.4 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Antibodies |
Fastest growing segment | Antibodies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibodies, Reagents, Equipment, Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG, Merck KGaA, Danaher Corp, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Abcam PLC, Cell Signaling Technology, Bio SB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunohistochemistry market will help companies and investors design strategic landscapes.
Antibodies was the largest segment with a revenue share of 42.32% in 2023. Horizon Databook has segmented the Italy immunohistochemistry market based on antibodies, reagents, equipment, kits covering the revenue growth of each sub-segment from 2018 to 2030.
As per World Cancer Research Fund, the age-standardized rate of cancer in Italy was 290.6 per 100,000 in 2018. The World Cancer Research Fund also stated that Italy is among the top 30 countries in terms of cancer incidence.
As per NCBI, gastric cancer is one of the common causes of death in Italian patients with immunodeficiency. IHC is also used for detecting infectious agents by using specific antibodies. According to WHO, Italy recorded its second chikungunya outbreak in 2017. Hence, these factors are expected to propel the growth of IHC market in Italy over the forecast period.
Furthermore, increase in number of partnerships and collaborations for improving access to new IHC solutions is anticipated to support regional growth. For instance, in September 2018, A. Menarini Diagnostics S.r.l., an Italian diagnostics solution provider, entered into a strategic partnership with Lunaphore Technologies SA, a Swiss cancer diagnostics company, to market Lunaphore’s LabSat Frozen, an innovative automated tissue staining solution, which can perform IHC assays within a few minutes.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy immunohistochemistry market , including forecasts for subscribers. This country databook contains high-level insights into Italy immunohistochemistry market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account